- The key vendors in the Global HER-2 Positive Breast Cancer Market 2015-2019 are Celgene Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novartis AG and Sanofi SA
London, 25 February 2015: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global HER-2 Positive Breast Cancer Market 2015-2019. The increase in prevalence of breast cancer resulting in a high rate of patient admissions, opting for the treatment regimen is a key driver of the market. The increase in urbanization, high life expectancy, and sedentary lifestyle has increased incidences of breast cancer. Unmet medical needs for safer drugs is another major driver of the market. Overall, the market is expected to grow at a CAGR of 9.90 percent during the forecast period of 2014-2019.
According to a 2014 publication by F. Hoffmann-La Roche, about 1.6 million incidences of breast cancer have been reported worldwide, with a mortality rate of 50,000 per annum due to HER-2 positive breast cancer. HER-2 positive breast cancer is diagnosed by measuring the level of HER-2 protein in the cancer cells. A sample of the tissue is collected from the breast using a biopsy, and the levels of HER-2 protein are checked.
“In the past decade, various targeted therapies have been introduced in the market for the treatment of breast cancer. These therapies cause fewer side effects than conventional chemotherapies. Drugs such as Herceptin and Kadcyla that target HER-2 receptors can be administered to patients as monotherapy or in combination,” says Faisal Ghaus, Vice President of TechNavio Research.
“Combination therapies, which target distinct mechanisms, have become highly efficient in treating the disease. Targeting multiple pathways might also reduce the risk of developing treatment-resistant cancers.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
